In a different study, Messa et al. evaluated the effect of iron chelators on NF-κB activation in myelodysplastic cells and in leukemia cell lines (K562 and HL60), these cells being characterized by a high basal NF-κB activity. Here, NFKB1 is linked to leukemia.